Orthofix s.r.l.
10
2
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
20.0%
2 terminated/withdrawn out of 10 trials
71.4%
-15.1% vs industry average
0%
0 trials in Phase 3/4
100%
5 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
TrueLok Elevate PMCF Study
Role: lead
Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb
Role: lead
Post-market Observational Study on JTIN Telescopic Nail in Osteogenesis Imperfecta Pediatric Patients
Role: lead
Observational Clinical Study on Elderly Patients With Fracture of the Proximal Femur Treated With the Chimaera Nail
Role: lead
Retrospective Evaluation of Guided Growth Plate System Plus's Safety and Clinical Performance for the Treatment of Lower Limbs Deformities.
Role: lead
Retrospective Study Chimaera Long Nail in Adult Patient
Role: lead
Study to Assess the Pain, Satisfaction, and Quality of Life of Patients With FITBONE® Lengthening Nail
Role: lead
Retrospective Study on Clinical Performance and Safety Profile of Agile Nail
Role: lead
Retrospective Study on Clinical Performance and Safety Profile of MJ-Flex Elastic Nail
Role: lead
Observational Study for the Evaluation of the Clinical Performance and Safety Profile of the GALAXY FIXATION™ System and Orthofix Implantable Devices: GALAXY Study
Role: lead
All 10 trials loaded